377 results
8-K
EX-99.1
sw40opyfj8aorhlm
26 Apr 24
AbbVie Reports First-Quarter 2024 Financial Results
7:43am
8-K
EX-4.2
sdbal0c4px b75tkc
26 Feb 24
Other Events
5:08pm
8-K
EX-1.1
0sa86d0 lrnzr5mj
26 Feb 24
Other Events
5:08pm
424B5
t7awrmz1aevv vvpl
26 Feb 24
Prospectus supplement for primary offering
6:12am
424B5
a4nnel
21 Feb 24
Prospectus supplement for primary offering
8:39am
8-K
EX-99.1
bm4m6iltdr b4kc0byf
12 Feb 24
AbbVie Completes Acquisition of ImmunoGen
7:49am
8-K
imj6xk iwq75x14eku
12 Feb 24
AbbVie Completes Acquisition of ImmunoGen
7:49am
8-K
EX-99.1
jif50i00x65y31x5q5
2 Feb 24
AbbVie Reports Full-Year and Fourth-Quarter 2023 Financial Results
7:51am
8-K
EX-99.1
cf4mghr
6 Dec 23
AbbVie to Acquire Cerevel Therapeutics in Transformative Transaction to Strengthen Neuroscience Pipeline
5:28pm
8-K
j1kh5rtjq
6 Dec 23
AbbVie to Acquire Cerevel Therapeutics in Transformative Transaction to Strengthen Neuroscience Pipeline
5:28pm
8-K
EX-99.2
sx1gana3
6 Dec 23
AbbVie to Acquire Cerevel Therapeutics in Transformative Transaction to Strengthen Neuroscience Pipeline
5:28pm